Trading For This Specialty Pharma Company is up Following Second Quarter Results
2023年8月11日 - 12:00AM
AllPennyStocks.com
This stock is almost a penny stock no longer, as shares moved
close to the $5 threshold following the firm’s quarterly
announcement. Leading pan-American (ex-US) specialty pharmaceutical
firm...
To read the full story on AllPennyStocks.com, click
here.
Knight Therapeutics (TSX:GUD)
過去 株価チャート
から 4 2024 まで 5 2024
Knight Therapeutics (TSX:GUD)
過去 株価チャート
から 5 2023 まで 5 2024
